CROI 2024 BHIVA working group summary-Reference-Cited by-同舟云学术

CROI 2024 BHIVA working group summary

Published:2024-09-10 Issue: Volume: Page:
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Medicine

Author:

Barber Tristan J.¹²^ORCID,Clarke Amanda³⁴,Fox Ashini⁵,Mackie Nicola E.⁶,Sabin Caroline²^ORCID,Waters Laura J.²⁷^ORCID

Affiliation:

1. Department of HIV Medicine Royal Free London NHS Foundation Trust London UK

2. Institute for Global Health University College London London UK

3. University Hospitals Sussex NHS Foundation Trust Brighton UK

4. Brighton and Sussex Medical School Brighton UK

5. Nottingham University Hospitals NHS Trust Nottingham UK

6. Imperial College Healthcare NHS Trust London UK

7. Department of Sexual Health & HIV Central and Northwest London NHS Foundation Trust London UK

Abstract

AbstractThe Conference on Retroviruses and Opportunistic Infections (CROI) is usually the most significant HIV conference of the year in terms of basic and clinical scientific output. CROI 2024 in Denver, USA, felt very much back to ‘business as usual’ following COVID‐19 disruptions that had impacted preceding years, but also felt more global and outward‐ facing. The British HIV Association supports a working group to attend CROI annually and deliver feedback in the UK. This article summarizes the highlights from that meeting.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13705

Reference69 articles.

1. HIV incidence in users of HIV preexposure prophylaxis in Australia: a whole‐of‐population analysis;Medland NA;CROI,2024

2. PrEP non‐persistence and new HIV diagnoses: a real ‐world analysis of >120,000 people prescribed PrEP;Tao L;CROI,2024

3. Persistence on contraception and PrEP in hair salons in South Africa;Bassett IV;CROI,2024

4. PrEP uptake and persistence among incarcerated people in Zambia: early results from a cohort study;Cassidy WC;CROI,2024

5. Mugo. Phone calls for PrEP persistence in Kenyan women in postabortal care: a cluster randomised trial;Heffron R;CROI,2024